Outpatient Hospital Infusion of Remdesivir
Customize your policy alerts
Sign up for medicaidoklahoma Policy OHCA PRN 2020-11 alerts
Get alerted when Policy OHCA PRN 2020-11 changes without checking for updates manually.
Monitor payer policy activity
This policy governs separate SoonerCare reimbursement for outpatient hospital infusion of Veklury (remdesivir) for members with moderate to severe COVID-19 who are stable enough to receive daily treatment while at home. It applies to hospital outpatient providers submitting claims for remdesivir infusion.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.